ASN Kidney Week 2019
ASN Kidney Week 2019
Advertisement
Victoria SochaASN Kidney Week 2019 | August 21, 2020
The oral hypoxia-inducible factor prolyl hydroxylase (HIF-PHI), roxadustat, is in last-stage development for the ...
Read More
Victoria SochaASN Kidney Week 2019 | April 19, 2023
In the OLYMPUS trial, researchers examined the efficacy of roxadustat for the treatment of anemia in patients with ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Researchers, led by Ajay Sharma, conducted a study designed to develop and validate a predictive model to identify ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Worldwide, the prevalence of chronic kidney disease (CKD) is on the rise. In the United States, approximately 15% of the ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Washington, DC—Patients with gastroesophageal reflux disease and peptic ulcer disease are commonly treated with proton ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Hyperkalemia, an electrolyte abnormality, is common in patients with chronic kidney disease (CKD). Treatment for ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Patiromer, a sodium-free potassium binder approved for treating hyperkalemia in adults is not currently approved for use ...
Victoria SochaASN Kidney Week 2019 | May 1, 2020
Increased excretion of urinary oxalate, enteric hyperoxaluria, can occur as a complication of fat malabsorption ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Washington, DC—Canagliflozin is US FDA approved for treatment of patients with type 2 diabetes and estimated ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Washington, DC—Patients with chronic kidney disease (CKD) who develop anemia may have reduced quality of life and ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Washington, DC—One of the earliest indicators of kidney disease is new-onset albuminuria, which is  predicted by an ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Washington, DC—There is no association between the distance between a patient’s residence and a kidney transplant ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Washington, DC—The treatment of choice for patients with end-stage renal disease is kidney transplantation, and living ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Patients with chronic kidney disease (CKD) who develop metabolic acidosis are at risk for accelerated decline in ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Washington, DC—Varying definitions of chronic kidney disease (CKD) and diagnosis accuracy in medical records ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Tolvaptan is approved for the treatment of adult patients with autosomal dominant polycystic kidney disease (ADPKD).
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Patients with autosomal dominant polycystic kidney disease (ADPKD) at highest risk for disease progression
Victoria SochaASN Kidney Week 2019 | April 19, 2023
The American College of Cardiology/American Heart Association (ACC/AHA) issued new hypertension guidelines in 2017 that ...
Victoria SochaASN Kidney Week 2019 | April 19, 2023
Results of studies have suggested that chronic kidney disease (CKD) is an independent predictor of stroke; the studies ...
Advertisement
Advertisement
Advertisement
Latest News

May 17, 2024